Found: 37
Select item for more details and to access through your institution.
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma.
- Published in:
- In Vivo, 2022, v. 36, n. 3, p. 1302, doi. 10.21873/invivo.12831
- By:
- Publication type:
- Article
mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2016, v. 54, n. 2, p. 315, doi. 10.1515/cclm-2015-0456
- By:
- Publication type:
- Article
Silencing of the DNA damage repair regulator PPP1R15A sensitizes acute myeloid leukemia cells to chemotherapy.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 8, p. 2853, doi. 10.1007/s00277-024-05785-x
- By:
- Publication type:
- Article
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 9, p. 2279, doi. 10.1007/s00277-021-04421-2
- By:
- Publication type:
- Article
Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1→HIF-1α pathway.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 3, p. 315, doi. 10.1007/s00277-010-1070-6
- By:
- Publication type:
- Article
Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 584, doi. 10.3390/jcm13020584
- By:
- Publication type:
- Article
Primary Adrenal Lymphomas with Cushing's Syndrome: Two Cases with Evidence of Endogeneous Cortisol Production by the Neoplastic Lymphoid Cells.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1917, doi. 10.3390/cancers14081917
- By:
- Publication type:
- Article
MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 593, doi. 10.3390/cancers13040593
- By:
- Publication type:
- Article
Immunophenotypic Profile of CD34+ Subpopulations and Their Role in the Diagnosis and Prognosis of Patients with De‐Novo, Particularly Low‐Grade Myelodysplastic Syndromes.
- Published in:
- Cytometry. Part B, 2019, v. 96, n. 1, p. 73, doi. 10.1002/cyto.b.21725
- By:
- Publication type:
- Article
A 3′ tRNA‐derived fragment produced by tRNA<sup>LeuAAG</sup> and tRNA<sup>LeuTAG</sup> is associated with poor prognosis in B‐cell chronic lymphocytic leukemia, independently of classical prognostic factors.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 6, p. 821, doi. 10.1111/ejh.13613
- By:
- Publication type:
- Article
A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis.
- Published in:
- Microorganisms, 2021, v. 9, n. 4, p. 806, doi. 10.3390/microorganisms9040806
- By:
- Publication type:
- Article
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211013987
- By:
- Publication type:
- Article
Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620720958299
- By:
- Publication type:
- Article
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720966121
- By:
- Publication type:
- Article
Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
- Published in:
- European Journal of Haematology, 2005, v. 75, n. 3, p. 193, doi. 10.1111/j.1600-0609.2005.00475.x
- By:
- Publication type:
- Article
Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 9, p. 1844, doi. 10.3390/v13091844
- By:
- Publication type:
- Article
MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
- Published in:
- Disease Markers, 2017, p. 1, doi. 10.1155/2017/2046545
- By:
- Publication type:
- Article
Plasmablastic Lymphoma in an Immunocompetent Patient with MDS/MPN with Ring Sideroblasts and Thrombocytosis—A Case Report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Acute cerebral ischemia with underlying myelodysplastic syndrome mimicking vaccine‐induced immune thrombotic thrombocytopenia.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 5, p. e9, doi. 10.1111/ene.15216
- By:
- Publication type:
- Article
Clinical characteristics and outcome of early‐stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3303
- By:
- Publication type:
- Article
Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 336, doi. 10.1002/hon.2842
- By:
- Publication type:
- Article
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher‐risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 541, doi. 10.1002/hon.2756
- By:
- Publication type:
- Article
Prognostic significance of monoclonal gammopathy in diffuse large B-cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Identification of a novel tRNA-derived RNA fragment exhibiting high prognostic potential in chronic lymphocytic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- Letter
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 1, p. 10, doi. 10.1002/hon.2012
- By:
- Publication type:
- Article
The prognostic value of monosomal karyotype (MK) in higher‐risk patients with myelodysplastic syndromes treated with 5‐Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 895, doi. 10.1002/ajh.25111
- By:
- Publication type:
- Article
Hypermethylation of the p15<sup> INK4B</sup> gene promoter in B-chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 9, p. 824, doi. 10.1002/ajh.20914
- By:
- Publication type:
- Article
The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas.
- Published in:
- Biomedicines, 2021, v. 9, n. 4, p. 333, doi. 10.3390/biomedicines9040333
- By:
- Publication type:
- Article
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard of Care.
- Published in:
- Oncologist, 2012, v. 17, n. 2, p. 239, doi. 10.1634/theoncologist.2011-0275
- By:
- Publication type:
- Article
The Novel Member of the BCL2 Gene Family, BCL2L12, Is Substantially Elevated in Chronic Lymphocytic Leukemia Patients, Supporting Its Value As a Significant Biomarker.
- Published in:
- Oncologist, 2011, v. 16, n. 9, p. 1280, doi. 10.1634/theoncologist.2010-0349
- By:
- Publication type:
- Article
Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.891961
- By:
- Publication type:
- Article
Novel circular RNAs of the apoptosis‐related BAX and BCL2L12 genes identified in a chronic lymphocytic leukemia cell line using nanopore sequencing.
- Published in:
- FEBS Open Bio, 2023, v. 13, n. 10, p. 1953, doi. 10.1002/2211-5463.13672
- By:
- Publication type:
- Article
Red Blood Cell Abnormalities as the Mirror of SARS-CoV-2 Disease Severity: A Pilot Study.
- Published in:
- Frontiers in Physiology, 2022, v. 12, p. 1, doi. 10.3389/fphys.2021.825055
- By:
- Publication type:
- Article
Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry-based cohort study.
- Published in:
- EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.30
- By:
- Publication type:
- Article
Erdheim–Chester Disease and Acute Myeloid Leukemia with Mutated NPM1 in a Patient with Clonal Hematopoiesis: A Case Report.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 11689, doi. 10.2147/OTT.S276497
- By:
- Publication type:
- Article